Direct interactions of androgenic/anabolic steroids with the peripheral benzodiazepine receptor in rat brain: Implications for the psychological and physiological manifestations of androgenic/anabolic steroid abuse

Journal of Steroid Biochemistry and Molecular Biology

Volumn 58, Issue 5-6, 1996, Pages 551-555

  Masonis, A E Tory ^a,b   McCarthy, Michael P ^a,c  

^a RUTGERS UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ANABOLIC AGENT; DRUG DERIVATIVE; ISOQUINOLINE DERIVATIVE; METHYLTESTOSTERONE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; NANDROLONE; STANOZOLOL; TESTOSTERONE; TESTOSTERONE 17 BETA CYPIONATE; TESTOSTERONE 17 BETA-CYPIONATE;

ADDICTION; ANIMAL; ARTICLE; BRAIN; DRUG POTENTIATION; IN VITRO STUDY; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT; SYNAPTOSOME;

ANABOLIC AGENTS; ANIMALS; BRAIN; ISOQUINOLINES; MALE; METHYLTESTOSTERONE; NANDROLONE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; STANOZOLOL; SUBSTANCE-RELATED DISORDERS; SYNAPTOSOMES; TESTOSTERONE;

EID: 0030203123     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(96)00075-1     Document Type: Article

References (25)

1. Turner A. J. and Whittle S. R.: Biochemical dissection of the γ-aminobutyrate synapse. Biochem. J. 209 (1983) 29-41.
2. Harris R. A. and Allan A. M.: Functional coupling of γ-aminobutyric acid receptors to chloride channels in brain membranes. Science 228 (1985) 1108-1110.
3. Bormann J., Hamill O. P. and Sakmann B.: Mechanism of anion permeation through channels gated by glycine and γ-aminobutyric acid in mouse cultured spinal neurons. J. Physiol. 385 (1987) 243-286.
4. Schofield P. R., Darlison M. G., Fujita N., Burt D. R., Stephenson F. A., Rodriguez H., Rhee L. M., Ramachandran J., Reale V., Glencorse T. A., Seeburg P. H. and Barnard E. A.: Sequence and functional expression of the GABAA receptor shows a ligand-gated receptor super-family. Nature 328 (1987) 221-227.
5. Papadopoulos V.: Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function. Endocr. Rev. 14 (1993) 222-240.
6. Basile A. S. and Skolnick P.: Subcellular localization of 'peripheral-type' binding sites for benzodiazepines in rat brain. J. Neurochem. 46 (1986) 305-308.
7. Costa E., Auta J., Guidotti A., Korneyev A. and Romeo E.: The pharmacology of neurosteroidogenesis. J. Steroid Biochem. Molec. Biol. 49 (1994) 385-389.
8. Majewska M. D.: Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Progr. Neurobiol. 38 (1992) 379-395.
9. Masonis A. E. T. and McCarthy M. P.: Androgenic-anabolic steroid-mediated effects on benzodiazepine binding to the GABAA receptor: a novel mechanism for receptor modulation J. Pharm. Exp. Ther. in press.
10. A receptor. Neurosci. Lett. 189 (1995) 35-38.
11. 35S]TBPS binding. J. Pharm. Exp. Ther. in press.
12. Hirsch J. D., Beyer C. F., Malkowitz L., Loullis C. C. and Blume A. J.: Characterization of ligand binding to mitochondrial benzodiazepine receptors. Molec. Pharmacol. 34 (1988) 164-172.
13. Decken J. and Marangos P. J.: Hormonal interactions with benzodiazepine binding sites in vitro. Life Sci. 39 (1986) 675-683.
14. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J.: Protein measurement with the folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275.
15. 3H]PK11195, an isoquinoline carboxamide derivative: kinetic studies and autoradiographic localization. J. Neurochem. 41 (1983) 1744-1750.
16. Ahima R. S. and Harlan R. E.: Regulation of receptor immunoreactivity in the rat hippocampus by androgenic-anabolic steroids. Brain Res. 585 (1992) 311-314.
17. Gavish M., Katz Y., Bar-Ami S. and Weizman R.: Bio-chemical, physiological, and pathological aspects of the peripheral benzodiazepine receptor. J. Neurochem. 58 (1992) 1589-1601.
18. Pope H. G. Jr. and Katz D. L.: Affective and psychotic symptoms associated with anabolic steroid use. Am. J. Psychiatr. 145 (1988) 487-490.
19. Su T.-P., Pagliaro M., Schmidt P. J., Pickar D., Wolkowitz O. and Rubinow D. R.: Neuropsychiatrie effects of anabolic steroids in male normal volunteers. JAMA 269 (1993) 2760-2764.
20. Pope H. G. Jr. and Katz D. L.: Psychiatric and medical effects of anabolic-androgenic steroid use. Arch. Gen. Psych. 51 (1994) 375-382.
21. Clark A. S. and Barber D. M.: Anabolic-androgenic steroids and aggression in castrated male rats. Physiol. Behav. 56 (1994) 1107-1113.
22. Schwarz S. and Pohl P.: Steroid hormones and steroid hormone binding globulins in cerebrospinal fluid studied in individuals with intact and with disturbed blood-cerebrospinal fluid barrier. Neuroendocrinology 55 (1992) 174-182.
23. Farges R., Joseph-Liauzun E., Shire D., Caput D., Le Fur G. and Ferrara P.: Site-directed mutagenesis of the peripheral benzodiazepine receptor: identification of amino acids implicated in the binding site of Ro5-4864. Molec. Pharmacol. 46 (1994) 1160-1167.
24. Itzhak Y. and Norenberg M. D.: Regulation of peripheral-type benzodiazepine receptors in cultured astrocytes by monoamine and amino acid neurotransmitters. Brain Res. 660 (1994) 346-348.
25. McEnery M. W., Snowman A. M., Trifiletti R. R. and Snyder S. H.: Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc. Natn. Acad. Sci. U.S.A. 89 (1992) 3170-3174.